Researcher Spotlight – Francisca Wetimane

Biography:

I am a Data Science student at IUT Besançon Vesoul Antenne Dole in France, with a particular interest in applying data-driven approaches to biological and medical research. Drawn to the intersection of technology and life sciences, I combine analytical thinking with a passion for understanding how cutting-edge science can solve real-world health challenges. My runners-up entry, Rewriting the Code of Life: How Gene Editing is Curing Sickle Cell Disease, reflects this curiosity  exploring how CRISPR-based therapy is revolutionising treatment for inherited blood disorders and what it means for the future of genetic medicine. I am a member of the BSGCT student community.

What advantages has being part of the BSGCT community brought you?

I’ll be honest  the BSGCT is entirely online for me, and yet it’s been one of the more genuinely useful communities I’ve been part of. There’s something freeing about an online space where people engage purely around ideas  no small talk, no politics, just people who care about the same problems you do. For someone working at the intersection of data science and gene therapy, finding that kind of focused, knowledgeable network isn’t easy. The BSGCT filled a gap I didn’t quite know I had.

 What has been your favourite, or most surprising, scientific finding?

The fetal haemoglobin story genuinely surprised me  but what surprised me almost as much was what the data behind it looked like. When I first dug into the genomic datasets around BCL11A expression, the signal was remarkably clean for something so biologically consequential. The idea that our bodies already carry a working solution to sickle cell disease, but simply silence it after birth, felt almost too elegant. As someone who spends a lot of time looking for patterns in noisy biological data, finding one this clear  and this actionable  was a rare moment.

What is the most important thing you have learned working in this field?

That the biology and the data have to speak to each other, or neither is very useful on its own. Coming from a data science background, I used to trust a strong statistical signal almost instinctively. But in gene therapy, you learn quickly that a clean result in your model doesn’t always translate to a clean result in a patient. The most important thing I’ve learned is to constantly move between the computational and the biological  to let each one challenge the other. That tension, uncomfortable as it sometimes is, is where the real understanding lives.